AptarGroup, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 29, 2021 at 05:12 pm EDT
Share
AptarGroup, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was USD 776.754 million compared to USD 721.553 million a year ago. Operating income was USD 92.591 million compared to USD 88.460 million a year ago. Net income was USD 83.952 million compared to USD 55.253 million a year ago. Basic earnings per share from continuing operations was USD 1.29 compared to USD 0.86 a year ago. Diluted earnings per share from continuing operations was USD 1.24 compared to USD 0.84 a year ago.
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
APTARGROUP, INC. 
